Pediatrics provides specialized medical care for infants, children, and adolescents. Learn about routine screenings, vaccinations, and treatments.
Send us all your questions or requests, and our expert team will assist you.
The management of Kawasaki disease is a medical urgency requiring rapid and decisive intervention. The overarching goal is to immediately suppress systemic inflammation and prevent immune-mediated destruction of the coronary artery endothelium. The therapeutic window is narrow; interventions are most effective when administered within the first 10 days of fever onset, although treatment is still indicated for children presenting later if active inflammation persists. The standard of care involves a potent combination of immunotherapy and anti-inflammatory agents. At Liv Hospital, treatment protocols are rigorous and evidence-based, designed to optimize outcomes even in high-risk or refractory patients. The care environment is structured to support both the child’s physiological needs and the family’s emotional needs during this acute crisis.
Intravenous Immunoglobulin (IVIG) remains the gold standard therapy for the acute phase of Kawasaki disease. It is a pooled blood product containing purified IgG antibodies derived from the plasma of thousands of donors. The mechanism of action is multifactorial: IVIG saturates Fc receptors on immune cells, neutralizes circulating superantigens and cytokines, and suppresses endothelial cell activation. The standard protocol dictates a single high dose (2 g/kg) administered over 10 to 12 hours. This high-dose bolus provides a potent anti-inflammatory “shock” to the system, capable of halting the vasculitis.
Aspirin (acetylsalicylic acid) is integral to the treatment regimen, serving two distinct physiological purposes based on the dosage administered. In the acute febrile phase, high-dose aspirin (80-100 mg/kg/day) is administered for its anti-inflammatory and antipyretic effects. It helps control the fever and reduce joint pain and mucosal swelling. Once the fever has resolved for at least 48 hours, the dose is reduced to a low antiplatelet dose (3-5 mg/kg/day). This lower dose inhibits platelet aggregation by blocking thromboxane A2 production, preventing clots from forming in the potentially damaged or turbulent coronary arteries. This low-dose regimen continues for 6 to 8 weeks, or longer if coronary artery abnormalities persist. The transition from high to low dose is a critical clinical decision point based on the child’s inflammatory markers and clinical status.
Approximately 10% to 20% of patients are “IVIG-resistant,” defined as persistent or recurrent fever 36 hours after the completion of the first IVIG infusion. These patients are at the highest risk for coronary artery damage. Treatment algorithms for refractory disease involve intensification of therapy. A second dose of IVIG is often the first step. If inflammation persists, corticosteroids (such as intravenous methylprednisolone) are administered. Pulse-dose steroids provide potent, broad-spectrum immune suppression. When steroids and repeat IVIG fail, biologic agents targeting specific cytokines are used. Infliximab (a TNF-alpha inhibitor) and Anakinra (an IL-1 receptor antagonist) are advanced therapies used to break the cycle of inflammation in these problematic cases. Cyclosporine, a calcineurin inhibitor, is another option for suppressing T-cell activation.
For children who develop medium or large coronary artery aneurysms (giant aneurysms), aspirin alone is insufficient to prevent thrombosis. The blood flow within a dilated aneurysm is sluggish and turbulent, creating a high-risk environment for clot formation. These patients require systemic anticoagulation in addition to aspirin. Warfarin (Coumadin) is the traditional agent, requiring careful monitoring of INR levels to ensure the blood is thin enough to prevent clots but not so thin as to cause bleeding. Low-molecular-weight heparin (Lovenox) injections are an alternative, particularly in infants, where oral dosing is difficult. The most modern approach may involve direct oral anticoagulants (DOACs) in specific scenarios. The goal is to maintain a delicate balance: preventing catastrophic clots in the coronary arteries while minimizing the risk of bleeding complications.
Beyond pharmacotherapy, inpatient care focuses on rigorous monitoring and supportive management. Cardiac telemetry is often used to detect arrhythmias associated with myocarditis. Frequent vital sign monitoring helps detect hypotension or tachycardia early. Nutritional support is critical, as oral pain may prevent adequate intake; nasogastric feeding or IV fluids may be necessary to maintain hydration. Pain management is tailored to the child’s needs, often requiring scheduled analgesics for mucositis and arthritis. Nursing care includes meticulous skin care for peeling extremities and eye care for conjunctivitis. The care team also educates the family on the signs of aspirin toxicity and the importance of avoiding viral exposure (like influenza/varicella) while on aspirin therapy.
Discharge planning begins once the fever has been absent for 24 to 48 hours. Parents are educated about administering aspirin and the crucial signs of aspirin toxicity (such as rapid breathing or vomiting). A critical component of home care is monitoring for fever recurrence, which warrants immediate medical re-evaluation. The peeling of the skin on hands and feet usually occurs after discharge; parents are reassured that this is a painless and expected part of the healing process. Follow-up appointments for repeat echocardiograms and blood tests are scheduled before discharge, ensuring continuity of care.
Send us all your questions or requests, and our expert team will assist you.
At first, a high dose is needed to combat the severe inflammation and fever. Once the fever subsides, the dose is reduced to prevent blood clotting.
At first, a high dose is needed to combat the severe inflammation and fever. Once the fever subsides, the dose is reduced to prevent blood clotting.
It is a blood product made from plasma, but it is not a transfusion of red blood cells. It provides antibodies that help calm the immune system.
You must be very careful. Medicines like ibuprofen can interfere with aspirin’s ability to protect the heart. Always check with the doctor before giving other drugs.
The main risk is bleeding and a rare condition called Reye syndrome if the child gets the flu or chickenpox. That is why flu shots are crucial for these children.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
